Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Sci Transl Med. 2024 Jan 24;16(731):eadd1834. doi: 10.1126/scitranslmed.add1834. Epub 2024 Jan 24.
Sci Transl Med. 2024.
PMID: 38266104
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
Vano YA, Phan L, Gravis G, Korakis I, Schlürmann F, Maillet D, Bennamoun M, Houede N, Topart D, Borchiellini D, Barthelemy P, Ratta R, Ryckewaert T, Hasbini A, Hans S, Emambux S, Cournier S, Braychenko E, Elaidi RT, Oudard S.
Vano YA, et al. Among authors: korakis i.
Int J Cancer. 2022 Oct 15;151(8):1335-1344. doi: 10.1002/ijc.34126. Epub 2022 Jun 6.
Int J Cancer. 2022.
PMID: 35603906
Free PMC article.
Item in Clipboard
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.
Cousin S, Cantarel C, Guegan JP, Mazard T, Gomez-Roca C, Metges JP, Bellera C, Adenis A, Korakis I, Poureau PG, Bourcier K, Toulmonde M, Kind M, Rey C, Auzanneau C, Bessede A, Soubeyran I, Italiano A.
Cousin S, et al. Among authors: korakis i.
Eur J Cancer. 2022 Feb;162:161-169. doi: 10.1016/j.ejca.2021.11.012. Epub 2022 Jan 5.
Eur J Cancer. 2022.
PMID: 34998048
Clinical Trial.
Item in Clipboard
Improving patient selection for immuno-oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center.
Al Darazi G, Martin E, Delord JP, Korakis I, Betrian S, Estrabaut M, Poublanc M, Gomez-Roca C, Filleron T.
Al Darazi G, et al. Among authors: korakis i.
Int J Cancer. 2021 May 15;148(10):2502-2511. doi: 10.1002/ijc.33409. Epub 2020 Dec 6.
Int J Cancer. 2021.
PMID: 33231298
Free article.
Item in Clipboard
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.
Ortiz Brugués A, Sibaud V, Herbault-Barrés B, Betrian S, Korakis I, De Bataille C, Gomez-Roca C, Epstein J, Vigarios E.
Ortiz Brugués A, et al. Among authors: korakis i.
Oncologist. 2020 Feb;25(2):e391-e395. doi: 10.1634/theoncologist.2019-0467. Epub 2019 Nov 6.
Oncologist. 2020.
PMID: 32043780
Free PMC article.
Item in Clipboard
Cite
Cite